Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-M Boher

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2018
The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patientsM Longué, B Cabarrou, J Wallet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 2017
Survival after breast cancer local recurrence according to therapeutic strategiesG Houvenaeghel, J M Boher, V Michel, et al.
Breast Cancer Research and Treatment|May 11, 2017
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature reviewB Cabarrou, L Mourey, F Dalenc, et al.
British Journal of Cancer|April 5, 2001
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsW Jacot, X Quantin, J M Boher, et al.
British Journal of Cancer|September 1, 1996
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancersJ L Pujol, J Simony, G Jolimoy, et al.
Contemporary Clinical Trials Communications|April 7, 2023
Aqua polo: Preliminary feasibility and efficacy study of a programme of adapted, supervised water polo to reduce fatigue and improve women's psychological and social recovery after breast cancer treatment: A mixed-methods designS Cuvelier, C Goetgheluck-Villaron, M Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?R Sabatier, J C Eymard, J Walz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
How to report toxicity associated with targeted therapies?B Cabarrou, J M Boher, E Bogart, et al.
Bone Marrow Transplantation|February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2018
The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patientsM Longué, B Cabarrou, J Wallet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 2017
Survival after breast cancer local recurrence according to therapeutic strategiesG Houvenaeghel, J M Boher, V Michel, et al.
Breast Cancer Research and Treatment|May 11, 2017
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature reviewB Cabarrou, L Mourey, F Dalenc, et al.
British Journal of Cancer|April 5, 2001
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsW Jacot, X Quantin, J M Boher, et al.
British Journal of Cancer|September 1, 1996
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancersJ L Pujol, J Simony, G Jolimoy, et al.
Contemporary Clinical Trials Communications|April 7, 2023
Aqua polo: Preliminary feasibility and efficacy study of a programme of adapted, supervised water polo to reduce fatigue and improve women's psychological and social recovery after breast cancer treatment: A mixed-methods designS Cuvelier, C Goetgheluck-Villaron, M Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?R Sabatier, J C Eymard, J Walz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
How to report toxicity associated with targeted therapies?B Cabarrou, J M Boher, E Bogart, et al.
Bone Marrow Transplantation|February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Pageof 3